Literature DB >> 10030714

Immunosurveillance and the evaluation of national immunization programmes: a population-based approach.

H E De Melker1, M A Conyn-van Spaendonck.   

Abstract

Mass vaccination can change the epidemiological dynamics of infectious diseases. It may result in a limited persistence of natural and vaccine-induced immunity and a higher mean age of infection, which may lead to a greater risk of complications. The epidemiological situation should be monitored and immunosurveillance based on the assessment of specific antibodies against vaccine-preventable diseases in human serum is one of the tools. In order to estimate the immunity of the Dutch population reliably, a large-scale, population-based, collection of serum samples was established (8359 sera in a nation-wide sampling and 1589 sera from municipalities with low vaccine coverage). In contrast to collecting residual sera from laboratories, this approach gains extensive information by means of a questionnaire regarding the determinants of the immune status and the risk factors for the transmission of infectious diseases in general. The population-based approach gives a better guarantee that the data are representative than collecting sera from laboratories does.

Entities:  

Mesh:

Year:  1998        PMID: 10030714      PMCID: PMC2809572          DOI: 10.1017/s0950268898001587

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  28 in total

1.  Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis.

Authors:  H E de Melker; F G Versteegh; M A Conyn-Van Spaendonck; L H Elvers; G A Berbers; A van Der Zee; J F Schellekens
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Reference values for the SERION classic ELISA for detecting Legionella pneumophila antibodies.

Authors:  H C Boshuizen; J W Den Boer; H de Melker; J F P Schellekens; M F Peeters; J A van Vliet; M A E Conyn-van Spaendonck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-14       Impact factor: 3.267

3.  Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus.

Authors:  Gaby P Smits; Pieter G van Gageldonk; Leo M Schouls; Fiona R M van der Klis; Guy A M Berbers
Journal:  Clin Vaccine Immunol       Date:  2012-01-11

Review 4.  The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseases.

Authors:  Sarah E Wilson; Shelley L Deeks; Todd F Hatchette; Natasha S Crowcroft
Journal:  CMAJ       Date:  2011-11-14       Impact factor: 8.262

5.  Seroepidemiology of human Toxocara and Ascaris infections in the Netherlands.

Authors:  Lapo Mughini-Gras; Margriet Harms; Wilfrid van Pelt; Elena Pinelli; Titia Kortbeek
Journal:  Parasitol Res       Date:  2016-05-27       Impact factor: 2.289

6.  Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey.

Authors:  C Amela; I Pachón; F de Ory
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

7.  Estimation of minimum infection rates with Legionella pneumophila in an exposed population.

Authors:  H C Boshuizen; N J D Nagelkerke; J W Den Boer; H De Melker; J F P Schellekens; M F Peeters; H Van Vliet; M A E Conyn-Van Spaendonck
Journal:  Epidemiol Infect       Date:  2005-10-20       Impact factor: 2.451

8.  Evaluation of an in-house cat scratch disease IgM ELISA to detect Bartonella henselae in a routine laboratory setting.

Authors:  M Herremans; J Bakker; M J Vermeulen; J F P Schellekens; M P G Koopmans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-05       Impact factor: 3.267

9.  Antibody levels after regular childhood vaccinations in the immunological screening of children with recurrent otitis media.

Authors:  Selma P Wiertsema; Elisabeth A M Sanders; Reinier H Veenhoven; Niels Van Heerbeek; Susan van den Hof; Guy A M Berbers; Ger T Rijkers
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

10.  The seroepidemiology of herpes simplex virus type 1 and 2 in Europe.

Authors:  R G Pebody; N Andrews; D Brown; R Gopal; H De Melker; G François; N Gatcheva; W Hellenbrand; S Jokinen; I Klavs; M Kojouharova; T Kortbeek; B Kriz; K Prosenc; K Roubalova; P Teocharov; W Thierfelder; M Valle; P Van Damme; R Vranckx
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.